Physician profile
Shishir Ojha
NPI 1225223803
$6,701.46
in general payments reported to CMS, 2019-2025
13 companies · $93.73 in 2025
The $93.73 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $15.45 · 2023: $3,108 · 2024: $3,045 · 2025: $93.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $246.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,016.99 | 2023-2024 | Ion, Da Vinci Surgical System |
| Olympus Corporation of The Americas | $222.52 | 2019 | |
| Glaxosmithkline, LLC. | $104.65 | 2019-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $70.45 | 2020-2023 | Breztri, Tezspire |
| Genentech USA, INC. | $50.92 | 2019 | |
| Abiomed | $43.95 | 2025 | |
| Philips North America LLC | $39.92 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.46 | 2019-2024 | Ofev |
| Grifols USA, LLC | $29.28 | 2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $26.47 | 2024 | Yupelri |
| Sunovion Pharmaceuticals INC. | $21.79 | 2019 | |
| Insmed, INC. | $20.50 | 2025 | Brinsupri, Arikayce |
| Amgen INC. | $19.56 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shishir Ojha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.